Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03683004 · ClinicalTrials.gov registry record
Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 40
- Enrollment target
NCT03683004 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 40 participants.
The verdict
NCT03683004 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Cancer treatments have successfully improved cancer outcomes but frequently negatively impact quality of life in cancer survivors. In particular, chemotherapy (CTX) has been associated with impaired cognitive abilities such as concentration and memory. The goal is to investigate the neural mechanisms of chemotherapy-related cognitive impairment (CRCI) using an interdisciplinary translational approach. Previous research in this area lacks diversity in studied cancer populations and treatments focusing primarily on breast cancer and provides limited understanding of how CRCI emerges from changes in neural structure, function, and connectivity. To overcome these limitations, this feasibility/pilot study aims to investigate CRCI in patients with colorectal cancer (CRC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-01-22 |
| Est. Completion | 2020-11-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03683004
The ClinicalTrials.gov registry entry for NCT03683004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03683004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03683004 about?
NCT03683004 is a clinical study titled "Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study". Cancer treatments have successfully improved cancer outcomes but frequently negatively impact quality of life in cancer survivors. In particular, chemotherapy (CTX) has been associated with impaired cognitive abilities such as concentration and memory. The goal is to investigate the neural mechanism...
What is the current status of trial NCT03683004?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-01-22. Estimated completion is 2020-11-25.
Who is sponsoring clinical trial NCT03683004?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.